480 - Oral Abstracts Session
Kidney Transplantation: Desensitization and other complications

Wednesday September 16, 2020 | 10:30 to 11:15
Room: Channel 6
Track: Kidney

Presentations

Ashley Vo, United States
Clazakizumab® (Anti-IL-6) for desensitization of highly-HLA sensitized patients awaiting kidney transplant (NCT03380962)

Dr. Stanley Jordan, United States
Clazakizumab (anti-IL-6) induces FoxP3+ Tregs in highly HLA sensitized patients receiving HLAi kidney transplantation (NCT03380962)

Dr. Matt J Bottomley DPhil, United Kingdom
CD8+ T cell senescence is a distinct immunological state that identifies long-term renal transplant recipients at increased risk of future malignancy

Prof. Binnaz Handan Ozdemir, Turkey
Rapamycin prevents interstitial fibrosis through decreasing peritubular capillary (PTC) VEGF expression and angiogenesis while inducing glomerular sclerosis and proteinuria through decreasing glomerular VEGF expression

Comments

There are no comments yet...



© 2024 TTS 2020